NFKB1 and central nervous system cancer: In order to inhibit NF-κB signaling we used Withaferin A (WA), a known inhibitor of NF-κB signaling, that can readily cross the blood-brain barrier and has demonstrated anti-tumor effects in glioma [40]–[44].